Article citationsMore>>

Meyer, C.H., Rodrigues, E.B., Michels, S., Mennel, S., Schmidt, J.C., Helb, H.M., Hager, A., Martinazzo, M. and Farah, M.E. (2010) Incidence of Damage to the Crystalline Lens during Intravitreal Injectio ns. Journal of Ocular Pharmacology and Therapeutics, 26, 491-495.
https://doi.org/10.1089/jop.2010.0045

has been cited by the following article:

• TITLE: Outcome of Cataract Surgery in Patients Treated for Retinopathy of Prematurity

  AUTHORS: Huy Nguyen, Kimberly G. Yen

  KEYWORDS: Pediatric Cataract, Retinopathy of Prematurity, Pediatric Cataract Surgery

  JOURNAL NAME: Open Journal of Ophthalmology, Vol.7 No.4, November 6, 2017

  ABSTRACT: Background/Aims: Pediatric patients with treated retinopathy of prematurity (ROP) may develop visually significant cataracts. We report the outcome of cataract surgery in patients who had ROP treatment. Method: Retrospective chart review of 19 eyes from 16 patients who had ROP treatment and subsequent cataract surgery between August, 2002 and March, 2015. Results: Eighteen of 19 eyes received laser treatment for ROP; 1 eye received intravitreal bevacizumab. 5 eyes received lens-sparing pars plana vitrectomy (LSPPV) in addition to laser. Average follow up was 10.1 ± 5.5 years. Average visual acuity improved from 20/324 prior to and 20/110 after cataract surgery (p = 0.06). 13/19 (68%) of the eyes received laser only and developed cataracts an average of 6.2 ± 5.6 years after laser treatment. 5/19 (26%) eyes developed cataracts an average of 6.4 ± 4.2 years after LSPPV and laser. In one eye, a cataract developed after a bevacizumab injection 2.9 years after the injection. Visual axis opacification (VAO) developed in 2/5 (40%) eyes after Ce/PCIOL/PPC-Antvx, 8/10 eyes (80%) after CE/IOL, and in 0/4 eyes after CE/PPC-AntVx. Ocular comorbidities included strabismus, nystagmus, amblyopia, optic atrophy, corneal band keratopathy, and phthisis bulbi. Conclusion: Cataract surgery in patients who have a history of ROP can be complicated by anatomical changes from prematurity and prior vitreoretinal surgeries. Vision improvement is limited by other ocular comorbidities.